DRD2 rs2283265: Understanding This Dopamine Receptor Variant
The rs2283265 variant is a single nucleotide polymorphism located within the DRD2 gene, which encodes a critical dopamine receptor in the brain. Researchers have investigated this variant to determine if it contributes to reproductive health conditions, specifically endometriosis-related infertility.
What each genotype means
Typical dopamine receptor profile
This genotype represents the most common form of this variant in many populations. Research into this specific marker has not consistently linked it to endometriosis-related infertility, and its role in other conditions remains a subject of ongoing study.
This is the most frequent genotype observed in many global populations.
Common heterozygous variant profile
Carrying one copy of the T allele has been investigated for its potential influence on DRD2 gene splicing, specifically regarding the inclusion of exon 6. While some studies have explored this variant in the context of reproductive health and psychiatric conditions, current evidence does not establish it as a definitive diagnostic risk factor.
This heterozygous genotype is commonly found across diverse ancestral groups.
Less common variant profile
This genotype is associated with the T allele, which has been shown in some molecular studies to favor the inclusion of exon 6 in the DRD2 gene. While researchers have examined this variant for potential links to infertility and neurological traits, results have been mixed and do not provide a clear clinical prediction for individuals.
This genotype is less common than the G/G or G/T combinations in most studied populations.
What is rs2283265?
The variant rs2283265 is a single nucleotide polymorphism (SNP) found on chromosome 11. In the context of human genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is situated within the DRD2 gene, which provides instructions for creating the dopamine receptor D2 protein. Because this SNP is located in a region associated with the regulation of dopamine signaling, it has been a subject of interest for scientists studying how genetic differences might influence neurological and physiological processes. It is categorized as a common variant, meaning it appears frequently across diverse human populations.
The Role of the DRD2 Gene
The DRD2 gene encodes the D2 dopamine receptor, a protein that plays a fundamental role in the central nervous system. Dopamine is a neurotransmitter that acts as a chemical messenger, and the D2 receptor is essential for transmitting these signals between neurons. Beyond its well-known role in reward-seeking behavior, executive control, and motor function, the DRD2 receptor is also involved in the endocrine system. Specifically, it helps regulate the secretion of prolactin from the pituitary gland. Because dopamine acts as a tonic inhibitor of prolactin, the proper functioning of these receptors is vital for maintaining hormonal balance. Disruptions in this pathway have led researchers to hypothesize that variations in the DRD2 gene could potentially influence conditions linked to hormonal regulation.
Research and Evidence Strength
The association between rs2283265 and reproductive health, particularly endometriosis-related infertility, has been explored in clinical studies. Some researchers hypothesized that variants in the DRD2 gene might contribute to hyperprolactinemia, a condition that can impact fertility. However, the evidence regarding rs2283265 as a direct risk factor remains limited and inconclusive. For instance, a study published in Molecular Medicine Reports investigated this specific SNP alongside others in women with endometriosis-related infertility and found no statistically significant difference in genotype or allele frequencies when compared to control groups. Consequently, while the gene itself is biologically relevant to hormonal pathways, the current scientific consensus does not establish rs2283265 as a definitive genetic cause for these reproductive conditions. Further large-scale research is required to clarify if any subtle associations exist.
Population Frequency
The rs2283265 variant is considered a common polymorphism. According to data from large-scale genomic databases like gnomAD and SNPedia, the minor allele frequency is approximately 0.21, indicating that the variant is widely distributed across various ancestral populations. Because it is common, it is expected to be found in a significant portion of the general population, regardless of health status.
Interpreting Genetic Information
It is important to approach genetic information with a clear understanding of its limitations. The presence of a specific genotype for rs2283265 does not constitute a medical diagnosis, nor does it predict the development of any reproductive or neurological condition. Genetic variants often have small, complex effects that are influenced by a wide range of environmental, lifestyle, and other genetic factors. If you have concerns about your reproductive health or hormonal balance, it is essential to consult with a qualified healthcare provider or a fertility specialist. They can provide personalized medical advice based on your clinical history and diagnostic testing, rather than relying on individual SNP data. Always discuss any health-related questions with a professional who can interpret your results within the context of your overall well-being.
How common is this variant?
The rs2283265 variant is common, with a minor allele frequency of approximately 0.21 across global populations.
Frequently asked questions
Does having the rs2283265 variant mean I will have fertility issues?
No. Current research has not established a definitive link between this variant and infertility. Genetic variants are only one small piece of a very complex puzzle involving many biological and environmental factors.
Is rs2283265 a diagnostic test for endometriosis?
No, this SNP is not used as a diagnostic tool. Endometriosis is diagnosed by healthcare professionals through clinical evaluation, imaging, and sometimes surgical procedures, not by genetic testing of single variants.
Can I change my health outcomes based on my DRD2 genotype?
Genetic information is fixed at birth. However, focusing on overall health, regular check-ups with your doctor, and maintaining a healthy lifestyle are the most effective ways to manage your well-being regardless of your genotype.
Where can I find more information about my specific genetic results?
If you have received genetic testing results, you should discuss them with a certified genetic counselor or your primary care physician. They can help you understand the clinical relevance of your results in the context of your personal health history.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2283265?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in DRD2
This SNP is located in a linkage disequilibrium block of the DRD2 gene and was evaluated for links to endometriosis-related infertility.
Commonly studied variant in the Dopamine D2 Receptor gene linked to cognitive flexibility and processing speed.
Also known as TaqIB, this dopamine receptor D2 intronic variant is associated with reward processing, cognitive flexibility, and sensory preference traits.
This SNP in the dopamine receptor D2 gene was investigated as a potential genetic risk factor for endometriosis-related infertility.
This variant in the dopamine receptor D2 gene has shown suggestive association with polysomnographically determined sleep latency.
The DRD2 TaqIB variant modulates dopamine D2 receptor density and has been widely investigated for associations with addiction susceptibility and therapeutic response to antipsychotics.